Syneos Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Syneos Health yıllık ortalama 34.5% oranında kazançlarını artırırken, Life Sciences sektöründe kazançlar growing at 13.9% annual. Gelirler growing yılda ortalama 6.4% oranında artmaktadır. Syneos Health'in özkaynak karlılığı 2% ve net marjı 1.3%'dir.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Life Sciences Sektör Büyümesin/a
Gelir büyüme oranın/a
Özkaynak getirisin/a
Net Marjn/a
Kazanç Güncellemesin/a

Yakın geçmiş performans güncellemeleri

Recent updates

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 29
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Mar 10
Does Syneos Health (NASDAQ:SYNH) Have A Healthy Balance Sheet?

Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Feb 20
Is Syneos Health, Inc. (NASDAQ:SYNH) Trading At A 40% Discount?

Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Dec 20
Should You Investigate Syneos Health, Inc. (NASDAQ:SYNH) At US$34.33?

Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Nov 28
Is Syneos Health (NASDAQ:SYNH) Using Too Much Debt?

Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Nov 01
Here's Why Syneos Health (NASDAQ:SYNH) Has Caught The Eye Of Investors

Syneos, Datavant expand partnership on data analytics for clinical trials

Oct 11

Syneos Health falls 13% after update on outlook

Sep 13

When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Sep 08
When Should You Buy Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Aug 22
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Syneos Health Q2 2022 Earnings Preview

Aug 01

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Jul 19
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Makes An Interesting Case

Syneos: Upside Could Be Priced In, Valuations Unsupportive

Jul 15

Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Jun 18
Is There An Opportunity With Syneos Health, Inc.'s (NASDAQ:SYNH) 49% Undervaluation?

Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Jun 03
Is Now The Time To Look At Buying Syneos Health, Inc. (NASDAQ:SYNH)?

We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

May 19
We Think Syneos Health (NASDAQ:SYNH) Can Stay On Top Of Its Debt

Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Apr 08
Do Syneos Health's (NASDAQ:SYNH) Earnings Warrant Your Attention?

Syneos Health: Upside Opportunity After Unexpected Correction In CRO Market, M&A Rumors

Mar 27

Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Mar 05
Is Now An Opportune Moment To Examine Syneos Health, Inc. (NASDAQ:SYNH)?

Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Feb 18
Is Syneos Health (NASDAQ:SYNH) A Risky Investment?

Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

Feb 03
Are Investors Undervaluing Syneos Health, Inc. (NASDAQ:SYNH) By 39%?

With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Jan 04
With EPS Growth And More, Syneos Health (NASDAQ:SYNH) Is Interesting

Syneos Health's Double-Digit Revenue Growth Sets The Tone For A Strong 2022

Dec 03

Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Dec 03
Is It Too Late To Consider Buying Syneos Health, Inc. (NASDAQ:SYNH)?

Gelir ve Gider Dağılımı

Syneos Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:SYNH Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 235,419716120
31 Mar 235,4141485690
31 Dec 225,3932665470
30 Sep 225,4072875590
30 Jun 225,4192785680
31 Mar 225,3402425740
31 Dec 215,2132355710
30 Sep 214,9802515420
30 Jun 214,7302365210
31 Mar 214,4611984840
31 Dec 204,4161934730
30 Sep 204,4891924640
30 Jun 204,5671874560
31 Mar 204,7201954590
31 Dec 194,6761315080
30 Sep 194,608864440
30 Jun 194,546174310
31 Mar 194,452194200
31 Dec 184,390244060
30 Sep 183,995-364340
30 Jun 183,472-1744260
31 Mar 182,658-1843680
31 Dec 171,853-1383140
30 Sep 171,365-862210
30 Jun 171,033891740
31 Mar 171,0331161740
31 Dec 161,0301131720
30 Sep 161,0091061710
30 Jun 169841161700
31 Mar 169521091640
31 Dec 159151171570
30 Sep 15887331540
30 Jun 1586081520
31 Mar 1583701490
31 Dec 14810-271450
30 Sep 14770131390
30 Jun 14732-11280
31 Mar 14687-271230
31 Dec 13652-421180
31 Dec 12579-601090

Kaliteli Kazançlar: SYNH büyük bir tek seferlik zarar ile $132.0M, 30th June, 2023 tarihine ait son 12 aylık mali sonuçları etkiliyor.

Büyüyen Kar Marjı: SYNH 'nin mevcut net kar marjları (1.3%) geçen yılın (5.1%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: SYNH son 5 yılda karlı hale geldi ve kazançlarını yıllık 34.5% oranında artırdı.

Büyüme Hızlandırma: SYNH 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: SYNH geçtiğimiz yıl negatif kazanç büyümesine ( -74.4% ) sahipti ve bu da onu Life Sciences sektör ortalamasıyla ( -4.7% ) karşılaştırmayı zorlaştırıyordu.


Özkaynak Getirisi

Yüksek ROE: SYNH 'nin Özsermaye Getirisi ( 2% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin